Pharmaceutical Industry in Japan Market Research & Statistics

You might be interested in: drug, vaccine, medicine, more »

About 700 reports

Download Unlimited Documents from Trusted Public Sources

Pharmaceutical Sales Demand in Japan

  • Reference Data
  • May 2014
    17 pages
  • Pharmaceutical  

  • Japan  

View report >

Pharmaceutical Sales Demand in Japan

  • Reference Data
  • May 2013
    18 pages
  • Pharmaceutical  

  • Japan  

View report >

Pharmaceutical Industry in Japan

  • Report on the Deliberation Results
  • March 2013
    82 pages
  • Endocrine, Nutr...  

    Drug  

    Clinical Trial  

  • Japan  

    Asia  

View report >

Pharmaceutical Industry in Japan

  • Risk Factors for Frequent Work-related Burn and Cut Injuries and...
  • January 2013
    10 pages
  • Pharmaceutical  

    Injuries  

  • Japan  

View report >

Pharmaceutical Demand Analysis in Japan - Forecast

  • Bridge Report
  • November 2012
    14 pages
  • Pharmaceutical  

  • Japan  

    Europe  

View report >

Pharmaceutical Markets in Japan - Forecast

  • Bridge Report
  • May 2012
    11 pages
  • Pharmaceutical  

  • Japan  

    United States  

View report >

Pharmaceutical Sales Demand in Japan

  • January 2012
    8 pages
  • Pathology  

    Glaucoma  

  • Japan  

    China  

View report >

Pharmaceutical Sales Demand in Japan - Forecast

  • Analysis Weak Yen Affects Revenues
  • January 2012
    6 pages
  • Pharmaceutical  

    Drug And Medica...  

  • Japan  

    Asia  

View report >

Pharmaceutical Industry

  • A Six-nation Survey of Cancer Knowledge and Attitudes
  • January 2012
    89 pages
  • Cancer  

  • Japan  

    United States  

    France  

View report >

Injuries Industry in Japan

  • Underreporting of Trayc Injuries Involving Children in Japan
  • July 2014
    4 pages
  • Injuries  

  • Japan  

    United States  

View report >


About 1 700 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 125 - $ 5 995)

OpportunityAnalyzer: Amyotrophic Lateral Sclerosis (ALS) - Opportunity Analysis and Forecasts to 2018

OpportunityAnalyzer: Amyotrophic Lateral Sclerosis (ALS) - Opportunity Analysis and Forecasts to 2018

  • $ 5 995
  • Industry report
  • June 2014
  • by Global Data

OpportunityAnalyzer: Amyotrophic Lateral Sclerosis (ALS) - Opportunity Analysis and Forecasts to 2018 Summary Amyotrophic lateral sclerosis (ALS) is a rare, but fatal, motor neuron disease (MND) characterized ...

Pharmapoint: Major Depressive Disorder - Japan Drug For ...

May 2014 $ 4 995

Marketview: Allergic Immunotherapies

July 2014 $ 4 495

Epicast Report: Acute Coronary Syndrome (acs) - Epidemi ...

July 2014 $ 3 995

Marketview - Chikungunya Vaccines

June 2014 $ 3 995

Critical Care Therapeutics In Major Developed Markets T ...

July 2014 $ 3 500

Glioblastoma Multiforme Therapeutics In Major Developed ...

June 2014 $ 3 500

Brexpiprazole (major Depressive Disorder) - Forecast An ...

May 2014 $ 3 495

Cariprazine (major Depressive Disorder) - Forecast And ...

May 2014 $ 3 495

Alks-5461 (major Depressive Disorder) - Forecast And Ma ...

May 2014 $ 3 495


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.